Heron Therapeutics – Consensus Indicates Potential 51.6% Upside

Broker Ratings

Heron Therapeutics found using ticker (HRTX) now have 10 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 70 and 22 calculating the average target price we see 32.1. Now with the previous closing price of 21.17 this would indicate that there is a potential upside of 51.6%. The day 50 moving average is 18.78 while the 200 day moving average is 16.67. The company has a market cap of $1,883m. You can visit the company’s website by visiting: http://www.herontx.com

Heron Therapeutics, a biotechnology company, engages in developing treatments to address unmet medical needs. The company’s product candidates utilize its proprietary Biochronomer drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron) extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing HTX-011, an investigational, dual-acting, and fixed-dose combination of the local anesthetic bupivacaine with a low dose of the nonsteroidal anti-inflammatory drug meloxicam that is in Phase III clinical trial for pain management; and HTX-034, a product candidate for postoperative pain management. The company was formerly known as A.P. Pharma and changed its name to Heron Therapeutics in January 2014. Heron Therapeutics was founded in 1983 and is headquartered in San Diego, California.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits

Good news travels fast (but only if you make that happen):

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on reddit
Reddit

AIM All Share Index